Insider Transactions in Q1 2021 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2021
|
John Maraganore Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,979
-1.37%
|
$5,062,871
$149.18 P/Share
|
|
Feb 25
2021
|
John Maraganore Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,979
+12.4%
|
$237,853
$7.1 P/Share
|
|
Feb 12
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,963
-15.67%
|
$302,302
$154.77 P/Share
|
|
Feb 12
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-9.61%
|
$301,475
$155.92 P/Share
|
|
Feb 12
2021
|
John Maraganore Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,719
-1.35%
|
$875,007
$153.97 P/Share
|
|
Feb 12
2021
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,710
-4.4%
|
$263,340
$154.26 P/Share
|
|
Feb 11
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,166
+39.43%
|
-
|
|
Feb 11
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,416
+34.6%
|
-
|
|
Feb 11
2021
|
John Maraganore Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,166
+6.27%
|
-
|
|
Feb 11
2021
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,416
+21.71%
|
-
|
|
Jan 13
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,027
-41.27%
|
$1,543,617
$171.0 P/Share
|
|
Jan 13
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,027
+35.64%
|
$731,187
$81.2 P/Share
|
|
Jan 12
2021
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,125
-39.33%
|
$503,125
$161.0 P/Share
|
|
Jan 12
2021
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+28.23%
|
$131,250
$42.22 P/Share
|
|
Jan 12
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,941
-63.42%
|
$2,420,442
$162.0 P/Share
|
|
Jan 12
2021
|
Laurie Keating EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,941
+37.41%
|
$881,519
$59.81 P/Share
|
|
Jan 11
2021
|
Laurie Keating EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
758
-25.33%
|
$116,732
$154.0 P/Share
|